Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 29, 2014 FORM 8-K
4 Sep 18, 2014 OWNERSHIP DOCUMENT
4 Sep 18, 2014 OWNERSHIP DOCUMENT
SC 13D/A Sep 17, 2014 SC 13D/A
8-K Aug 29, 2014 FORM 8-K
SC 13D/A Aug 28, 2014 SC 13D/A
4 Aug 15, 2014 FORM 4
4 Aug 15, 2014 FORM 4
10-Q Aug 7, 2014 10-Q
4 Jul 24, 2014 OWNERSHIP DOCUMENT
3 Jul 24, 2014 OWNERSHIP DOCUMENT
8-K Jul 24, 2014 8-K
CT ORDER Jul 18, 2014
8-K Jun 27, 2014 8-K
8-K Jun 18, 2014 FORM 8-K
8-K Jun 13, 2014 FORM 8-K
8-K May 30, 2014 FORM 8-K
8-K May 22, 2014 FORM 8-K
10-Q May 8, 2014 FORM 10-Q
10-K Mar 13, 2014 FORM 10-K
SC 13G Feb 12, 2014 SC 13G
SC 13G/A Feb 12, 2014
8-K Feb 12, 2014 FORM 8-K
SC 13G Jan 28, 2014
8-K Jan 13, 2014 CURRENT REPORT
← Newer Page 21 of 38 · 935 filings Older →